Tags

Type your tag names separated by a space and hit enter

[Therapy of degenerative maculopathy with Cosaldon A + E].

Abstract

Results of long-term treatment with Cosaldon A + E in 173 patients (= 345 eyes) exhibiting various stages of degenerative maculopathy are presented (5 tables and 4 figures). Depending on the initial status up to 80% of the treated eyes responded positively to this therapy with only a small side-effect rate: these results suggest that Cosaldon A + E is a promising alternative in the treatment of degenerative maculopathy.

Links

  • Publisher Full Text
  • Authors

    Source

    MeSH

    Aged
    Drug Combinations
    Female
    Fluorescein Angiography
    Humans
    Long-Term Care
    Macular Degeneration
    Male
    Middle Aged
    Nicotinic Acids
    Theobromine
    Visual Acuity
    Visual Fields
    Vitamin A
    Vitamin E

    Pub Type(s)

    English Abstract
    Journal Article

    Language

    ger

    PubMed ID

    3106705

    Citation

    Flamm, P. "[Therapy of Degenerative Maculopathy With Cosaldon a + E]." Klinische Monatsblatter Fur Augenheilkunde, vol. 190, no. 1, 1987, pp. 59-66.
    Flamm P. [Therapy of degenerative maculopathy with Cosaldon A + E]. Klin Monbl Augenheilkd. 1987;190(1):59-66.
    Flamm, P. (1987). [Therapy of degenerative maculopathy with Cosaldon A + E]. Klinische Monatsblatter Fur Augenheilkunde, 190(1), pp. 59-66.
    Flamm P. [Therapy of Degenerative Maculopathy With Cosaldon a + E]. Klin Monbl Augenheilkd. 1987;190(1):59-66. PubMed PMID: 3106705.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - [Therapy of degenerative maculopathy with Cosaldon A + E]. A1 - Flamm,P, PY - 1987/1/1/pubmed PY - 1987/1/1/medline PY - 1987/1/1/entrez SP - 59 EP - 66 JF - Klinische Monatsblatter fur Augenheilkunde JO - Klin Monbl Augenheilkd VL - 190 IS - 1 N2 - Results of long-term treatment with Cosaldon A + E in 173 patients (= 345 eyes) exhibiting various stages of degenerative maculopathy are presented (5 tables and 4 figures). Depending on the initial status up to 80% of the treated eyes responded positively to this therapy with only a small side-effect rate: these results suggest that Cosaldon A + E is a promising alternative in the treatment of degenerative maculopathy. SN - 0023-2165 UR - https://www.unboundmedicine.com/medline/citation/3106705/[Therapy_of_degenerative_maculopathy_with_Cosaldon_A_+_E]_ L2 - http://www.thieme-connect.com/DOI/DOI?10.1055/s-2008-1050331 DB - PRIME DP - Unbound Medicine ER -